摘要
目的:探讨富硒康口服液治疗消化性溃疡病的临床意义。方法:采用双盲对照法,治疗组:富硒康+雷尼替丁;对照组:雷尼替丁。结果:治疗组溃疡愈合率明显高于对照组(P<0.01),胃溃疡显效率为83.3%;十二指肠溃疡显效率为88.8%。结论:富硒康与H2受体拮抗剂对治疗消化性溃疡病有协同作用,它既有治疗用途,同时又起保健作用。
Obyective: To study the clinical signification of treating ulcerous disease of active digestibility by Fuxikang.Methods: Used random sample methods,treated group is Fuxikang+Rainitiding and control group is Ranitidine.Results: Cure rate of ulcerousdisease were significantly higher in the treated group than in the control group(P<0.01),the effective rate of the gastric ulcer is 83.3% and the duodenum ulcer is 88.8%.Conclusion: There are cooperate with function for treated ulcerous disease of digestibility by Fuxikang and the antagon of H_2 acceptor.Fuxikang play an important role in the cure and the health care.
出处
《微量元素与健康研究》
CAS
2006年第6期9-11,共3页
Studies of Trace Elements and Health
关键词
富硒康
硒
溃疡
Fuxikang
Selenium
Ulcer
